Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.55 CHF | +3.33% | +5.00% | +20.29% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Business Summary
Number of employees: 22,633
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Generics
77.0
%
| 6,820 | 78.7 % | 6,679 | 77.0 % | -2.07% |
Biosimilars
23.0
%
| 1,841 | 21.3 % | 1,991 | 23.0 % | +8.10% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
35.5
%
| 1,932 | 22.3 % | 3,073 | 35.5 % | +59.07% |
International
25.9
%
| 2,361 | 27.3 % | 2,242 | 25.9 % | -5.03% |
United States
16.8
%
| 1,565 | 18.1 % | 1,453 | 16.8 % | -7.17% |
Germany
12.9
%
| 1,121 | 12.9 % | 1,114 | 12.9 % | -0.62% |
North America
5.3
%
| - | - | 460 | 5.3 % | - |
Switzerland
3.8
%
| 275 | 3.2 % | 326 | 3.8 % | +18.60% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 431,000,000 | 394,591,722 ( 91.55 %) | 1,070,754 ( 0.2484 %) | 91.55 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.29% | 15.43B | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- SDZ Stock
- Company Sandoz Group AG